Basic info
Industry
biotechnology research
Sectors
Biotechnology
Biotechnologies
Health Care
Targeted Radionuclide Therapy
Oncology
Radiopharmaceuticals
Camel derived antibodies
Date founded
2014
Funding rounds raised
Total raised
$88M
from 14 investors over 14 rounds
P
Precirix raised $88M on March 16, 2022
Investors: Gimv, Pontifax Venture Capital, Inkef, HealthCap, Novo Holdings, V-Bio Ventures, BioMedPartners and Forbion
P
Precirix raised $42M on November 15, 2018
Investors: Gimv, BioMedPartners, Novo Holdings, V-Bio Ventures, HealthCap and Pontifax Venture Capital